Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors

Clinical trial NCT07551778 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07551778
Sponsor: BOE Technology Group Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

NSCLC (Advanced Non-small Cell Lung Cancer)Colorectal Cancer Advanced Solid Tumors

Start date: 2026-08-01
Primary completion: 2028-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.